Alexander Hardy

President and CEO, BioMarin Pharmaceutical

San Rafael, California

About

Alexander Hardy is the President and Chief Executive Officer of BioMarin Pharmaceutical and a member of its board. BioMarin is a rare disease biotechnology company that develops and sells medicines for genetically defined conditions, and it is headquartered in San Rafael, California. Hardy has held the CEO role since December 2023. Before BioMarin he spent nearly 20 years at Genentech and its parent Roche.

Hardy holds a B.A. in Land Economy from the University of Cambridge and an M.B.A. from the University of Michigan Ross School of Business. His early career included leadership roles at Novartis and Genentech. At Roche he led Asia Pacific for Roche Pharma from May 2014 to August 2016 and global product strategy from August 2016 to March 2019. He then became Chief Executive Officer of Genentech in May 2019. Other biotech and pharmaceutical chief executives with pages on Whoo include Reshma Kewalramani of Vertex Pharmaceuticals and Yvonne Greenstreet of Alnylam Pharmaceuticals.

In BioMarin's third-quarter 2026 results release he is quoted as President and Chief Executive Officer.

Whoo compiled this page from public sources: BioMarin 2026 proxy statement (SEC), BioMarin Q3 2026 results filing (SEC), Wikipedia: BioMarin Pharmaceutical. It is not affiliated with or endorsed by Alexander Hardy. Are you Alexander Hardy? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

President and Chief Executive Officer — BioMarin Pharmaceutical


December 2023 – Present | San Rafael, California

  • Leads the company and serves on its board
  • Chief Executive Officer — Genentech


    May 2019

    Head of Global Product Strategy — Roche


    August 2016 – March 2019

    Head, Asia Pacific, Roche Pharma — Roche


    May 2014 – August 2016

    Earlier leadership roles — Genentech and Novartis

  • Nearly 20 years at Genentech and Roche in total

Education

BA in Land Economy — University of Cambridge

MBA — University of Michigan, Ross School of Business

Projects